Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation.

adjuvant antigen delivery system design immunization rational route vaccine

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
06 Apr 2021
Historique:
received: 16 01 2021
revised: 05 03 2021
accepted: 08 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Vaccines are the most effective medical intervention due to their continual success in preventing infections and improving mortality worldwide. Early vaccines were developed empirically however, rational design of vaccines can allow us to optimise their efficacy, by tailoring the immune response. Establishing the immune correlates of protection greatly informs the rational design of vaccines. This facilitates the selection of the best vaccine antigens and the most appropriate vaccine adjuvant to generate optimal memory immune T cell and B cell responses. This review outlines the range of vaccine types that are currently authorised and those under development. We outline the optimal immunological correlates of protection that can be targeted. Finally we review approaches to rational antigen selection and rational vaccine adjuvant design. Harnessing current knowledge on protective immune responses in combination with critical vaccine components is imperative to the prevention of future life-threatening diseases.

Identifiants

pubmed: 33917629
pii: pharmaceutics13040501
doi: 10.3390/pharmaceutics13040501
pmc: PMC8067490
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Austrian Science Fund FWF
ID : P 28915
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 32397
Pays : Austria

Références

Vaccine. 1994 May;12(6):503-7
pubmed: 8036823
J Biol Chem. 2001 Nov 16;276(46):43111-21
pubmed: 11535603
Vaccine. 2015 Jun 8;33 Suppl 2:B14-20
pubmed: 26022561
PLoS One. 2016 Sep 27;11(9):e0163511
pubmed: 27673328
J Virol. 2020 Jan 6;94(2):
pubmed: 31645444
Nat Commun. 2015 Oct 28;6:8761
pubmed: 26508369
Adv Drug Deliv Rev. 2021 Mar;170:1-25
pubmed: 33359141
Infect Immun. 2013 Sep;81(9):3317-25
pubmed: 23798540
Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15614-21
pubmed: 25349379
ACS Cent Sci. 2020 Sep 23;6(9):1602-1616
pubmed: 32999936
Rev Med Virol. 2020 Jul;30(4):e2101
pubmed: 32101634
Drugs. 2011 Aug 20;71(12):1591-622
pubmed: 21861544
J Immunol. 2008 Dec 1;181(11):7925-35
pubmed: 19017983
Med Res Rev. 2019 Sep;39(5):1447-1484
pubmed: 30548868
Nat Rev Genet. 2008 Oct;9(10):776-88
pubmed: 18781156
Cell. 2019 Sep 5;178(6):1313-1328.e13
pubmed: 31491384
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
Cell. 2015 Jan 15;160(1-2):37-47
pubmed: 25594173
Vaccine. 2016 Feb 17;34(8):1025-33
pubmed: 26801064
Trends Mol Med. 2020 Jul;26(7):627-629
pubmed: 32418724
Curr Opin Immunol. 2000 Aug;12(4):456-63
pubmed: 10899018
Semin Immunol. 2018 Oct;39:14-21
pubmed: 29801750
Infect Immun. 2016 Apr 22;84(5):1424-1437
pubmed: 26902727
Int Immunol. 2014 Jun;26(6):307-14
pubmed: 24380872
Immunity. 2010 Oct 29;33(4):516-29
pubmed: 21029962
Microorganisms. 2020 Oct 03;8(10):
pubmed: 33022961
Vet Immunol Immunopathol. 2016 Jan;169:15-26
pubmed: 26827834
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Trends Pharmacol Sci. 2017 Sep;38(9):771-793
pubmed: 28668223
PLoS One. 2018 May 7;13(5):e0196950
pubmed: 29734365
PLoS One. 2013 Apr 26;8(4):e62622
pubmed: 23638128
Chemistry. 2015 Jan 7;21(2):500-19
pubmed: 25353096
Clin Vaccine Immunol. 2007 Nov;14(11):1499-504
pubmed: 17715328
Cold Spring Harb Perspect Med. 2021 Jun 1;11(6):
pubmed: 32152245
Microbiology (Reading). 1995 Aug;141 ( Pt 8):1993-2002
pubmed: 7551062
Hum Vaccin. 2011 Oct;7(10):1012-8
pubmed: 21941097
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
NPJ Vaccines. 2017 Feb 9;2:3
pubmed: 29263864
J Infect Dis. 2019 Apr 8;219(Suppl_1):S88-S96
pubmed: 30715361
Int J Pept Res Ther. 2021;27(1):779-799
pubmed: 33144851
Nature. 2014 Oct 9;514(7521):187-92
pubmed: 25119034
PLoS Pathog. 2012;8(11):e1003001
pubmed: 23144616
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-1924
pubmed: 33332292
Science. 2000 Mar 10;287(5459):1816-20
pubmed: 10710308
Curr Protein Pept Sci. 2012 Dec;13(8):807-15
pubmed: 23305366
Science. 2013 Sep 13;341(6151):1246-9
pubmed: 23887873
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18214-9
pubmed: 24145434
Hum Vaccin Immunother. 2017 May 4;13(5):1059-1072
pubmed: 28281864
Int Immunopharmacol. 2013 Dec;17(4):1090-3
pubmed: 24183654
Nature. 2014 Mar 13;507(7491):201-6
pubmed: 24499818
Vaccine. 2012 Mar 30;30(16):2633-9
pubmed: 22365841
J Biol Chem. 2000 Apr 14;275(15):11222-8
pubmed: 10753930
Methods Mol Biol. 2010;626:1-14
pubmed: 20099117
Hum Vaccin Immunother. 2013 Feb;9(2):259-64
pubmed: 23291951
J Med Chem. 2017 Sep 28;60(18):7745-7763
pubmed: 28829599
PLoS Pathog. 2009 Oct;5(10):e1000625
pubmed: 19834553
Cell. 2017 May 18;169(5):862-877.e17
pubmed: 28502771
Bioorg Med Chem Lett. 2015 Feb 1;25(3):547-53
pubmed: 25553892
Clin Exp Allergy. 2011 Sep;41(9):1305-12
pubmed: 21672053
Methods Mol Biol. 2016;1404:289-298
pubmed: 27076306
J Immunol Methods. 2015 Sep;424:111-9
pubmed: 26031451
mBio. 2017 May 9;8(3):
pubmed: 28487429
AIDS Res Hum Retroviruses. 1996 May 20;12(8):683-93
pubmed: 8744579
Front Microbiol. 2019 Apr 16;10:738
pubmed: 31040832
Clin Cancer Res. 2009 Sep 1;15(17):5323-37
pubmed: 19723653
Immunity. 2010 Oct 29;33(4):530-41
pubmed: 21029963
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):246-53
pubmed: 26379068
Arch Pharm Res. 2018 Feb;41(2):219-228
pubmed: 29147873
Hum Gene Ther. 2014 Apr;25(4):318-27
pubmed: 24593243
FEMS Microbiol Rev. 2019 May 1;43(3):257-272
pubmed: 30649292
Cancer Immunol Immunother. 2016 Jul;65(7):805-12
pubmed: 26842127
Biologicals. 2011 Jan;39(1):23-8
pubmed: 20965746
Br J Pharmacol. 2009 May;157(2):153-65
pubmed: 18776913
J Clin Med. 2019 Apr 10;8(4):
pubmed: 30974886
Eur J Biochem. 2000 Apr;267(7):2008-13
pubmed: 10727940
Nat Immunol. 2004 Oct;5(10):987-95
pubmed: 15454922
Expert Rev Vaccines. 2015;14(9):1255-75
pubmed: 26268434
Clin Transl Immunology. 2019 Nov 29;8(12):e1095
pubmed: 31798878
Lancet. 2020 Aug 15;396(10249):479-488
pubmed: 32702299
NPJ Vaccines. 2020 Jul 27;5(1):69
pubmed: 32793398
Lancet. 2017 Sep 23;390(10101):1511-1520
pubmed: 28754494
J Infect Dis. 1998 Jul;178(1):92-100
pubmed: 9652427
Curr Top Med Chem. 2008;8(2):64-79
pubmed: 18289078
Hum Vaccin Immunother. 2016 Oct 2;12(10):2709-2711
pubmed: 27551808
J Biol Chem. 1994 May 20;269(20):14402-10
pubmed: 8182046
NPJ Vaccines. 2018 Oct 3;3:41
pubmed: 30302283
Nucleic Acids Res. 2011 Nov;39(21):e142
pubmed: 21890902
Immunobiology. 2018 Jan;223(1):38-48
pubmed: 29031421
Front Cell Infect Microbiol. 2020 Oct 28;10:573348
pubmed: 33194812
Vaccine. 2016 May 17;34(23):2616-21
pubmed: 27091689
Vaccine. 1991 May;9(5):309-18
pubmed: 1872014
Nat Biotechnol. 2007 Dec;25(12):1361-6
pubmed: 18066025
Nat Rev Immunol. 2020 Oct;20(10):615-632
pubmed: 32887954
Nat Commun. 2014 Oct 30;5:5106
pubmed: 25355435
Glycobiology. 2005 May;15(5):561-70
pubmed: 15610978
Drugs. 2017 Nov;77(17):1881-1896
pubmed: 29094312
Infect Immun. 2012 Sep;80(9):3215-24
pubmed: 22753374
Front Cell Infect Microbiol. 2014 Feb 21;4:22
pubmed: 24600592
Int J Med Microbiol. 2009 Apr;299(4):233-46
pubmed: 19121604
Vaccine. 2019 May 27;37(24):3167-3178
pubmed: 31047671
PLoS One. 2012;7(7):e41529
pubmed: 22855691
Chem Commun (Camb). 2020 Jan 16;56(5):719-722
pubmed: 31833496
Cell Host Microbe. 2020 Sep 9;28(3):465-474.e4
pubmed: 32798445
Nat Immunol. 2014 Feb;15(2):195-204
pubmed: 24336226
J Clin Invest. 2016 Mar 1;126(3):799-808
pubmed: 26928033
Nat Rev Chem. 2021;5(3):197-216
pubmed: 33521324
Expert Rev Vaccines. 2007 Oct;6(5):723-39
pubmed: 17931153
Expert Rev Vaccines. 2011 Apr;10(4):499-511
pubmed: 21506647
Biochem Biophys Res Commun. 1986 Oct 30;140(2):557-64
pubmed: 3778467
Cold Spring Harb Perspect Med. 2013 May 01;3(5):a012476
pubmed: 23637311
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Lancet. 2020 Jun 13;395(10240):1845-1854
pubmed: 32450106
Chem Sci. 2018 Mar 15;9(16):3957-3963
pubmed: 29780528
PLoS One. 2017 Mar 9;12(3):e0173559
pubmed: 28278280
Mol Cancer. 2019 Nov 4;18(1):152
pubmed: 31679519
Vaccine. 2016 Dec 7;34(50):6436-6448
pubmed: 28029542
J Am Soc Mass Spectrom. 2017 Dec;28(12):2716-2723
pubmed: 28924631
Eur J Immunol. 2012 Jan;42(1):101-9
pubmed: 22002164
Cell Mol Immunol. 2008 Apr;5(2):91-7
pubmed: 18445338
Curr Opin Immunol. 2019 Aug;59:49-56
pubmed: 31029909
Immunity. 2008 Jul 18;29(1):150-64
pubmed: 18631455
Nat Commun. 2020 May 20;11(1):2601
pubmed: 32433465
Vaccine. 2007 Jul 26;25(30):5563-76
pubmed: 17292514
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Lancet. 1990 Jun 16;335(8703):1436-8
pubmed: 1972216
Hum Vaccin. 2011 Jan-Feb;7 Suppl:115-9
pubmed: 21245666
Sci Signal. 2011 May 03;4(171):ra28
pubmed: 21540455
J Biol Chem. 2003 Jul 25;278(30):27502-12
pubmed: 12743115
J Med Chem. 2005 Aug 11;48(16):5112-22
pubmed: 16078831
Acc Chem Res. 2016 Sep 20;49(9):1741-56
pubmed: 27568877
Curr Med Chem. 2013;20(16):2068-79
pubmed: 23531213
Front Immunol. 2019 May 24;10:1087
pubmed: 31178860
Semin Immunol. 2018 Oct;39:4-13
pubmed: 30396811
Clin Transl Immunology. 2016 Nov 02;5(11):e108
pubmed: 27990284
Cell. 2018 May 31;173(6):1385-1397.e14
pubmed: 29706550
Nat Rev Drug Discov. 2020 Oct;19(10):667-668
pubmed: 32887942
Curr Opin Immunol. 2020 Aug;65:57-64
pubmed: 32504952
Lancet Infect Dis. 2019 Sep;19(9):1013-1022
pubmed: 31351922
Expert Rev Vaccines. 2018 Sep;17(9):833-849
pubmed: 30173619
Cell Mol Life Sci. 2008 Oct;65(20):3231-40
pubmed: 18668203
Nat Chem. 2014 Jul;6(7):635-43
pubmed: 24950335
J Med Chem. 2018 Apr 12;61(7):2707-2724
pubmed: 29543461
PLoS Pathog. 2020 Jun 26;16(6):e1008522
pubmed: 32589686
J Am Chem Soc. 2019 Mar 6;141(9):4063-4072
pubmed: 30726084
Trends Immunol. 2020 Jun;41(6):457-465
pubmed: 32340868
Sci Transl Med. 2015 Oct 14;7(309):309ra162
pubmed: 26468324
J Biol Chem. 2004 May 14;279(20):21046-54
pubmed: 14766898
Science. 2013 Sep 13;341(6151):1250-3
pubmed: 24031018
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12294-9
pubmed: 25136133
Vaccine. 2010 Jul 5;28(30):4810-6
pubmed: 20483197
J Clin Invest. 2019 Nov 1;129(11):4769-4785
pubmed: 31566579
Vaccines (Basel). 2014 Jul 29;2(3):624-41
pubmed: 26344749
Expert Rev Vaccines. 2017 Aug;16(8):789-809
pubmed: 28586278
Immunol Lett. 2013 Jan;149(1-2):110-8
pubmed: 23018032
Hum Vaccin. 2006 Mar-Apr;2(2):45-53
pubmed: 17012886
Expert Rev Vaccines. 2007 Oct;6(5):773-84
pubmed: 17931157
Med Microbiol Immunol. 2015 Apr;204(2):205-13
pubmed: 25187406
Bioorg Med Chem. 2006 Oct 1;14(19):6759-77
pubmed: 16828560
Chem Rev. 2020 Mar 25;120(6):3210-3229
pubmed: 31804810
Chemistry. 2021 Mar 8;27(14):4731-4737
pubmed: 33236801
J Infect Dis. 1986 Mar;153(3):628-33
pubmed: 3950444
Vaccine. 2009 Jun 24;27 Suppl 2:B3-12
pubmed: 19481313
J Med Chem. 2014 Oct 9;57(19):8056-71
pubmed: 25252784
Nat Struct Mol Biol. 2016 Sep;23(9):811-820
pubmed: 27478931
J Exp Med. 2016 Apr 4;213(4):469-81
pubmed: 27022144
Annu Rev Med. 2019 Jan 27;70:91-104
pubmed: 30691364
Cold Spring Harb Perspect Biol. 2017 Nov 1;9(11):
pubmed: 28159875
Innate Immun. 2013 Oct;19(5):493-503
pubmed: 23339926
Vaccine. 1998 Jan-Feb;16(2-3):216-24
pubmed: 9607033
Annu Rev Biochem. 2007;76:295-329
pubmed: 17362200
Mol Pharm. 2018 Dec 3;15(12):5446-5453
pubmed: 30359030
Nat Commun. 2018 Mar 13;9(1):1051
pubmed: 29535307
Vaccine. 1995 Jan;13(1):77-82
pubmed: 7762283
Sci Rep. 2016 Nov 14;6:36575
pubmed: 27841285
Drugs Aging. 2018 Dec;35(12):1031-1040
pubmed: 30370455

Auteurs

Virgil Schijns (V)

Intravacc, Institute for Translational Vaccinology (Intravacc), Utrecht Science Park, 3721 MA Bilthoven, The Netherlands.
Epitopoietic Research Corporation (ERC), 5374 RE Schaijk, The Netherlands.

Dragomira Majhen (D)

Laboratory for Cell Biology and Signalling, Division of Molecular Biology, Ruđer Bošković Instiute, HR-10000 Zagreb, Croatia.

Peter van der Ley (P)

Intravacc, Institute for Translational Vaccinology (Intravacc), Utrecht Science Park, 3721 MA Bilthoven, The Netherlands.

Aneesh Thakur (A)

Department of Pharmacy, University of Copenhagen, 2100 Copenhagen, Denmark.

Artur Summerfield (A)

Institute of Virology and Immunology, 3147 Mittelhausern, Switzerland.
Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.

Rita Berisio (R)

Institute of Biostructures and Bioimaging, National Research Council, I-80134 Naples, Italy.

Cristina Nativi (C)

Department of Chemistry "Ugo Schiff", University of Florence, 50019 Sesto Fiorentino, Italy.

Alberto Fernández-Tejada (A)

Chemical Immunology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Biscay Science and Technology Park, 48160 Derio-Bilbao, Spain.
Ikerbasque, Basque Foundation for Science, 48009 Bilbao, Spain.

Carmen Alvarez-Dominguez (C)

Facultativo en plantilla (Research Faculty), Instituto de Investigación Marqués de Valdecilla (IDIVAL), 39011 Santander, Spain.

Sveinbjörn Gizurarson (S)

Faculty of Pharmaceutical Sciences, University of Iceland, 107 Reykjavik, Iceland.
Department of Pharmacy, College of Medicine, University of Malawi, Blantyre 3, Malawi.

Alla Zamyatina (A)

Department of Chemistry, University of Natural Resources and Life Sciences, 1190 Vienna, Austria.

Antonio Molinaro (A)

Department of Chemical Sciences, University of Napoli Federico II, Complesso Universitario Monte Santangelo, I-80126 Napoli, Italy.
Department of Chemistry, School of Science, Osaka University, 1-1 Osaka University Machikaneyama, Toyonaka, Osaka 560-0043, Japan.

Camillo Rosano (C)

Proteomics and Mass Spectrometry Unit, IRCCS Policlinico San Martino, 16132 Genova-1, Italy.

Žiga Jakopin (Ž)

Faculty of Pharmacy, University of Ljubljana, 1000 Ljubiljana, Slovenia.

Ihsan Gursel (I)

Molecular Biology and Genetics Department, Science Faculty, Bilkent University, Bilkent, 06800 Ankara, Turkey.

Siobhán McClean (S)

School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, D04 V1W8 Dublin, Ireland.

Classifications MeSH